Access Keys:
Skip to content (Access Key - 0)

Center For Cancer Research National Cancer Institute
JB6 Mouse Model

JB6 References 2008
  1. Zheng D, Cho YY, Lau AT, Zhang J, Ma WY, Bode AM, & Dong Z. Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation. Cancer Res 68(18): 7650-60, 2008. Abstract Full Text
  2. Lee KW, Kang NJ, Rogozin EA, Oh SM, Heo YS, Pugliese A, Bode AM, Lee HJ, & Dong Z. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int J Cancer 123(11): 2487-96, 2008.  Abstract  Full Text
  3. Dey S, Bakthavatchalu V, Tseng MT, Wu P, Florence RL, Grulke EA, Yokel RA, Dhar SK, Yang HS, Chen Y, & St Clair DK. Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. Carcinogenesis 29(10): 1920-9, 2008.  Abstract  Full Text
  4. Jung SK, Lee KW, Byun S, Kang NJ, Lim SH, Heo YS, Bode AM, Bowden GT, Lee HJ, & Dong Z. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res 68(14): 6021-9, 2008.  Abstract  Full Text
  5. Qin J, Chen HG, Yan Q, Deng M, Liu J, Doerge S, Ma W, Dong Z, & Li DW. Protein phosphatase-2A is a target of epigallocatechin-3-gallate and modulates p53-Bak apoptotic pathway. Cancer Res 68(11): 4150-62, 2008. Erratum in. Cancer Res 68(16):6859, 2008.  Abstract  Full Text